“Foreign Direct Investment in Singapore: The Case of Pharmaceutical & Biological Products Sector”. Catallaxy 9, no. 1 (October 23, 2024): 7–15. Accessed December 6, 2024. https://journals.economic-research.pl/cxy/article/view/3330.